Discrepancies in the use of medications their extent and predictors in an outpatient practice

Archives of Internal Medicine

Volumn 160, Issue 14, 2000, Pages 2129-2134

  Bedell, Susanna E ^a,b   Jabbour, Samer ^a,b   Goldberg, Robert ^c   Glaser, Helene ^a   Gobble, Susan ^d   Young Xu, Yinong ^a   Graboys, Thomas B ^a,b   Ravid, Shmuel ^a,b  

^a Lown Cardiovascular Center   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d Memorial Health Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; DOCTOR PATIENT RELATION; DRUG MISUSE; DRUG UTILIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OUTCOMES RESEARCH; OUTPATIENT CARE; POLYPHARMACY; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

EID: 0034710230     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.14.2129     Document Type: Article

References (47)

1. Brennan TA, Leape LL, Laird N, et al. Incidence of adverse events and negligence in hospitalized patients: results from the Harvard Medical Practice Study I. N Engl J Med. 1991;324:370-376.
2. Bates DW, Cullen D, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274:29-34.
3. Lesar TS, Briceland L, Stein D. Factors related to errors in medication prescribing. JAMA. 1997;277:312-317.
4. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301-306.
5. Colley CA, Lucas LM. Polypharmacy: the cure becomes the disease. J Gen Intern Med. 1993;8:278-283.
6. Johnson JA, Bootman LJ. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med. 1995;155:1949-1956.
7. Gurwitz JH, Avorn J. The ambiguous relation between aging and adverse drug reactions. Ann Intern Med. 1991;114:956-966.
8. Monette J, Gurwitz JH, Avorn J. Epidemiology of adverse drug events in the nursing home setting. Drugs Aging. 1995;7:203-211.
9. Classen DC, Pestotnik SL, Evens RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991;266:2847-2851.
10. Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the Coronary Drug Project. N Engl J Med. 1980;303:1038-1041.
11. Gallagher EJ, Viscoli CM, Horwitz RI. The relationship of treatment adherence to the risk of death after myocardial infarction in women. JAMA. 1993;270:742-744.
12. Horwitz RI, Viscoli CM, Berkmar L, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet. 1990;336:542-545
13. Psaty BM, Koepsell TD, Wagner EH, LoGerfo JP, Inui TS. The relative risk of incident coronary heart disease associated with recently stopping the use of β-blockers. JAMA. 1990;263:1653-1657.
14. Miller NH. Compliance with treatment regimens in chronic asymptomatic diseases. Am J Med. 1997;102:43-49.
15. McDermott MM, Schmitt B, Wallner E. Impact of medication nonadherence on coronary heart disease outcomes. Arch Intern Med. 1997;137:1921-1929.
16. Gurwitz JH, Yeomans SM, Glynn RJ, Lewis BE, Levin RM, Avorn J. Patient non-compliance in the managed care setting: the case of medical therapy for glaucoma. Med Care. 1998;36:357-369.
17. Pillans PI. Toxicity of herbal products. N Z Med J. 1995;108:469-471.
18. McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. CMAJ. 1996;155:293-295.
19. Ginkgo biloba for dementia. Med Lett Drugs Ther. 1998;40:63-64.
20. Graboys TB, Blatt CM, Ravid S. Optimal medical therapy reduces referrals for invasive cardiovascular procedures. Am Coll Cardiol Curr J Rev. January/February 1997:81-84.
21. Straka RJ, Fish JT, Benson SR, Suh JT. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy. 1997;17:126-132.
22. Wagner MM, Hogan WR. The accuracy of medication data in an outpatient electronic medical record. JAMA. 1996;3:234-244.
23. Monson RA, Bond CA. The accuracy of the medical record as an index of outpatient drug therapy. JAMA. 1978;240:2182-2184.
24. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Oullette VL. How often is medication taken as prescribed? JAMA. 1989;261:3273-3277.
25. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med. 1994;154:433-437.
26. Rudd P, Tul V, Browr K, Davidson SM, Bostwick GJ. Hypertension continuation adherence: natural history and role as an indicator condition. Arch Intern Med. 1979;139:545-549.
27. Skaer TL, Sclar DA, Robison LM, et al. Effect of pharmaceutical formulation for antihypertensive therapy on health service utilization. Clin Ther. 1993;15: 715-725.
28. Dekker FW, Dieleman FE, Kaptein AA, Mulder JD. Compliance with pulmonary medication in general practice. Eur Respir J. 1993;6:886-890.
29. Price D, Cooke J, Singleton S, Feely M. Doctors' unawareness of the drugs their patients are taking: a major cause of overprescribing? BMJ. 1986;292:99-100.
30. Monane M, Bohn RL, Gurwitz JH, Glynn RJ, Levin R, Avorn J. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health. 1996;86:1805-1808.
31. Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med. 1993;153:1863-1868.
32. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med. 1990; 150:841-845.
33. Murphy J, Coster G. Issues in patient compliance. Drugs. 1997;54:797-800.
34. Friedman GD, Collen MF, Harris LE, Van Brunt EE, Davis LS. Experience in monitoring drug reactions in outpatients: The Kaiser-Permanente Drug Monitoring System. JAMA. 1971;217:567-572.
35. Steel K, Gertman PM, Crescenzi C, Anderson J. latrogenic illness on a general medical service at a university hospital. N Engl J Med. 1981;304:638-642.
36. Shapiro S, Slone D, Lewis GP, Jick H. Fatal drug reactions among medical inpatients. JAMA. 1971;216:467-472.
37. Lazarou J, Pomeranz, BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. JAMA. 1998;279:1200-1205.
38. Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilit es. Arch Intern Med. 1997;157:2089-2096.
39. Bedell SE, Deitz DC, Leeman D, Delbanco TL. Incidence and characteristics of preventable latrogenic cardiac arrests. JAMA. 1991;265:2815-2820.
40. Sanson-Fisher RW, Clover K. Compliance in the treatment of hypertension: a need for action. Am J Hypertens. 1995;8:82S-88S.
41. Friedman RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension: impact on medication adherence and blood pressure control. Am J Hypertens. 1996;9:285-292.
42. Wasson J, Gaudette C, Whaley F, et al. Telephone care as a substitute for routine clinic follow-up. JAMA. 1992;267:1788-1793.
43. Kruse W, Koch-Gwinner P, Nikolaus T, Oster P, Schlierf G, Weber E. Measurement of drug compliance by continuous electronic monitoring: a pilot study in elderly patients discharged from hospital. J Am Geriatr Soc. 1992;40:1151-1155.
44. Muirhead G. Consenting adults. Drug Top. 1996;140:56.
45. Schiff GD, Rucker D. Computerized prescribing: building the electronic infrastructure for better medication usage. JAMA. 1998;279:1024-1030.
46. Miller LG, Matson CC, Rogers JC. Improving prescription documentation in the ambulatory setting. Fam Pract Res J. 1992;12:421-429.
47. Colvin R. Prescription Drug Abuse: The Hidden Epidemic. Omaha, Neb: Addicus Books Inc; 1998:21-25.